| Dr Grant R Williams, MD | |
|
2000 6th Ave S, Birmingham, AL 35233-2110 | |
| (205) 934-9999 | |
| Not Available |
| Full Name | Dr Grant R Williams |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 15 Years |
| Location | 2000 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316181241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 35028 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dch Healthcare Authority | 8123271343 | 14 |
News Archive
Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.
The "scientific community, AIDS activists and Libyan government would do well to recognize ... the political and diplomatic import of the case" involving five Bulgarian nurses and one Palestinian doctor accused of infecting Libyan children with HIV, Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in a PLoS Medicine opinion piece (Garrett, PLoS Medicine, 10/26).
As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, The International examines the findings that "despite child vaccinations hitting a record-high with about 106 million infants being immunised this year, life-saving vaccines fail to reach some 24 million children in 72 of the world's poorest countries," many of whom, "are estimated to be most at risk from vaccine-preventable diseases," the publication writes.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Integrating artificial intelligence to analyze imaging data allows early recognition of heart disease, saving patients' time, money and, most importantly, lives.
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.
The "scientific community, AIDS activists and Libyan government would do well to recognize ... the political and diplomatic import of the case" involving five Bulgarian nurses and one Palestinian doctor accused of infecting Libyan children with HIV, Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in a PLoS Medicine opinion piece (Garrett, PLoS Medicine, 10/26).
As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, The International examines the findings that "despite child vaccinations hitting a record-high with about 106 million infants being immunised this year, life-saving vaccines fail to reach some 24 million children in 72 of the world's poorest countries," many of whom, "are estimated to be most at risk from vaccine-preventable diseases," the publication writes.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Integrating artificial intelligence to analyze imaging data allows early recognition of heart disease, saving patients' time, money and, most importantly, lives.
› Verified 8 days ago
| Entity Name | Dch Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699019539 PECOS PAC ID: 8123271343 Enrollment ID: O20130118000385 |
News Archive
Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.
The "scientific community, AIDS activists and Libyan government would do well to recognize ... the political and diplomatic import of the case" involving five Bulgarian nurses and one Palestinian doctor accused of infecting Libyan children with HIV, Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in a PLoS Medicine opinion piece (Garrett, PLoS Medicine, 10/26).
As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, The International examines the findings that "despite child vaccinations hitting a record-high with about 106 million infants being immunised this year, life-saving vaccines fail to reach some 24 million children in 72 of the world's poorest countries," many of whom, "are estimated to be most at risk from vaccine-preventable diseases," the publication writes.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Integrating artificial intelligence to analyze imaging data allows early recognition of heart disease, saving patients' time, money and, most importantly, lives.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Grant R Williams, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 801-8000 | Dr Grant R Williams, MD 2000 6th Ave S, Birmingham, AL 35233-2110 Ph: (205) 934-9999 |
News Archive
Over a year after the outbreak of Salmonella in peanut butter that sickened hundreds and caused the deaths of at least nine, criminal prosecution of the responsible parties has yet to begin.
The "scientific community, AIDS activists and Libyan government would do well to recognize ... the political and diplomatic import of the case" involving five Bulgarian nurses and one Palestinian doctor accused of infecting Libyan children with HIV, Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in a PLoS Medicine opinion piece (Garrett, PLoS Medicine, 10/26).
As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, The International examines the findings that "despite child vaccinations hitting a record-high with about 106 million infants being immunised this year, life-saving vaccines fail to reach some 24 million children in 72 of the world's poorest countries," many of whom, "are estimated to be most at risk from vaccine-preventable diseases," the publication writes.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Integrating artificial intelligence to analyze imaging data allows early recognition of heart disease, saving patients' time, money and, most importantly, lives.
› Verified 8 days ago
Juan Mario Bernal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |